Xact Kapitalforvaltning AB purchased a new stake in shares of Select Medical Holdings (NYSE:SEM) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 12,611 shares of the health services provider’s stock, valued at approximately $223,000.
A number of other large investors have also recently bought and sold shares of the stock. BlackRock Inc. raised its holdings in Select Medical by 3.0% during the 4th quarter. BlackRock Inc. now owns 13,836,694 shares of the health services provider’s stock valued at $244,216,000 after buying an additional 408,230 shares during the last quarter. Hood River Capital Management LLC raised its holdings in Select Medical by 133.0% during the 4th quarter. Hood River Capital Management LLC now owns 2,407,432 shares of the health services provider’s stock valued at $42,491,000 after buying an additional 1,374,111 shares during the last quarter. Victory Capital Management Inc. raised its holdings in Select Medical by 2.3% during the 4th quarter. Victory Capital Management Inc. now owns 1,252,350 shares of the health services provider’s stock valued at $22,104,000 after buying an additional 27,997 shares during the last quarter. Schwab Charles Investment Management Inc. raised its holdings in Select Medical by 2.9% during the 3rd quarter. Schwab Charles Investment Management Inc. now owns 994,780 shares of the health services provider’s stock valued at $19,100,000 after buying an additional 27,796 shares during the last quarter. Finally, Boston Partners raised its holdings in Select Medical by 7.7% during the 4th quarter. Boston Partners now owns 896,050 shares of the health services provider’s stock valued at $15,815,000 after buying an additional 64,003 shares during the last quarter. Institutional investors own 76.45% of the company’s stock.
A number of research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 14th. ValuEngine downgraded shares of Select Medical from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, March 7th. TheStreet raised shares of Select Medical from a “c+” rating to a “b-” rating in a research report on Thursday, March 1st. JMP Securities raised shares of Select Medical from an “underperform” rating to a “market perform” rating and set a $12.00 price objective on the stock in a research report on Tuesday, February 27th. Finally, Robert W. Baird reissued a “buy” rating and set a $26.00 price objective on shares of Select Medical in a research report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $20.63.
Shares of Select Medical stock opened at $18.10 on Tuesday. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 2.87. The firm has a market cap of $2,393.76, a price-to-earnings ratio of 18.66, a P/E/G ratio of 1.19 and a beta of 1.28. Select Medical Holdings has a 12-month low of $12.98 and a 12-month high of $19.77.
Select Medical (NYSE:SEM) last issued its quarterly earnings data on Wednesday, February 21st. The health services provider reported $0.31 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.19 by $0.12. The business had revenue of $1.11 billion for the quarter, compared to the consensus estimate of $1.10 billion. Select Medical had a net margin of 3.99% and a return on equity of 14.27%. The company’s quarterly revenue was up 6.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.12 EPS. analysts forecast that Select Medical Holdings will post 1.07 earnings per share for the current year.
In other news, insider Scott A. Romberger sold 5,000 shares of the company’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $18.46, for a total value of $92,300.00. Following the sale, the insider now directly owns 167,811 shares of the company’s stock, valued at approximately $3,097,791.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 19.86% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “Xact Kapitalforvaltning AB Purchases Shares of 12,611 Select Medical Holdings (SEM)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this news story on another site, it was illegally copied and republished in violation of international copyright law. The legal version of this news story can be viewed at https://www.dispatchtribunal.com/2018/04/17/xact-kapitalforvaltning-ab-purchases-shares-of-12611-select-medical-holdings-sem.html.
Select Medical Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company operates through four segments: Long Term Acute Care, Inpatient Rehabilitation, Outpatient Rehabilitation, and Concentra.
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings (NYSE:SEM).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.